Recent News for EQ - Equillium, Inc.

Date Title
Nov 15 Equillium Featured in Panel Discussion at Capital Markets Day for Kidney Health
Nov 12 Equillium EPS beats by $0.05
Nov 12 Equillium Announces Leadership Updates
Nov 12 Equillium Reports Third Quarter 2019 Financial Results and Recent Highlights
Nov 7 Equillium to Present at Investor Conferences in November 2019
Nov 6 Equillium to Present New Data and Insights on the CD6-ALCAM Pathway in Lupus Nephritis at ACR 2019
Oct 31 Orgenesis Appoints Bala S. Manian to its Scientific Advisory Board
Oct 4 Healthcare - Top 5 Gainers / Losers
Oct 1 Equillium Announces Initiation of the EQUALISE Phase 1b Clinical Trial of Itolizumab for Patients with Lupus Nephritis and Provides Business Update
Sep 19 Will Equillium, Inc. (NASDAQ:EQ) Need To Raise More Money?
Sep 17 Equillium to Host Business Update Call on October 1, 2019
Aug 27 Equillium to Present at H. C. Wainwright 21st Annual Global Investment Conference
Aug 12 Equillium EPS beats by $0.06
Aug 12 Equillium Reports Second Quarter 2019 Financial Results and Recent Highlights
Aug 7 The Daily Biotech Pulse: Novartis Stands By Zolgensma, GW Pharma Q2 Propelled By Epidiolex Sales, Ionis-Akcea Clinical Readout
Jul 26 Stocks That Managed to Breach 52-Week Lows Friday
Jul 10 Equillium Announces Initiation of the EQUIP Phase 1b Clinical Trial of Itolizumab for Patients with Uncontrolled Asthma
Jul 2 Amarin and Celyad among healthcare gainers; CEL-SCI and Oramed Pharmaceuticals among losers
Jul 2 Benzinga's Top Upgrades, Downgrades For July 2, 2019
May 23 Equillium to Present at Jefferies 2019 Healthcare Conference
Back to the Main EQ Page...